Abstract. The use of microfluidics for biofluid analysis offers a cheaper alternative to conventional techniques in disease diagnosis. However, traditional microfluidics design may be complicated by the need to incorporate separation elements into the system in order to facilitate specific molecular detection. Alternatively, an optical technique known as surface-enhanced Raman spectroscopy ͑SERS͒ may be used to enable identification of analyte molecules directly from a complex sample. This will not only simplify design but also reduce overall cost. The concept of SERS-based microfluidics is however not new and has been demonstrated previously by mixing SERSactive metal nanoparticles with a model sample, in situ, within the microchannel. Although the SERS reproducibility of these systems was shown to be acceptable, it is, however, not stable toward variations in the salt content of the sample, as will be shown in this study. We have proposed a microfluidics design whereby periodic SERSactive metal nanostructures are fabricated directly into the microchannel via a simple method of spin coating. Using artificial as well as human urine samples, we show that the current microfluidics is more stable toward variations in the sample's ionic strength.
Introduction
Biofluids contain vital medical information that is often used for patient diagnosis when symptomatic information is ambiguous. [1] [2] [3] [4] Generally, a biofluid analysis would involve detection of a specific molecule of interest within a complex sample, which conventionally entails the use of such separation techniques as high-performance liquid chromatography or high-performance capillary electrophoresis, which are time-consuming procedures. 5, 6 The isolated molecule can then be quantitated by some optical means, which is a preferred choice for reason of economic. However, the amount of starting materials needed by these approaches is often considerable, which can be a practical issue especially in a clinical setting. 7 A microfluidic device, consisting of miniaturized fluidic networks fabricated on a polymer platform, represents an effective way of handling a minute amount of biofluid samples for chemical and biochemical analysis. [8] [9] [10] [11] [12] A sample volume of ϳ1 ml or less would be sufficient in any microfluidic experiment. Furthermore, both mixing and chemical reaction of the sample with reagents can be performed in one single microfluidic chip. It is also possible to monitor the reaction near realtime, owing to the small size of the device, thereby reducing the analysis time and providing a point-of-care capability. 13 In addition to these, microfluidics also offers a means for mass-produced, low-cost, single-use devices for disease screening and diagnosis. 14, 15 In order to serve as a self-contained platform, microfluidics must be able to provide a means for molecular identification. As such, an in-chip purification system has been developed that allows a molecule of interest to be separated out from the sample or mixture of products generated from the biochemical reaction. 13, 16, 17 Unfortunately, microfluidic separation suffers from the same problems of irreproducible migration times as in capillary electrophoresis ͑CE͒ due to the channel wall characteristic. In another example, a specific fluorescent labeler is introduced into the microchannel that tags itself to the target molecules, thereby allowing them to be separated optically, 18 or alternatively a mass spectrometer may be used, at the expense of an increased system cost. 19 Raman spectroscopy, on the other hand, can identify a specific chemical within a sample without the need of molecule separation. [20] [21] [22] It is a cheap alternative as a read-out system ͑$6,000 to $150,000͒ compared to a mass spectroscopy ͑Ͼ$500,000͒ and, thus, a more favorable choice for lab-inthe-office applications. Furthermore, simultaneous detection of multiple analytes via Raman is possible owing to the narrow peaks in a Raman spectrum, which minimizes spectral overlap. The combination of Raman with microfluidics may thus lead to a much simpler design and hence affordable commercial price per chip.
Raman spectroscopy works by measuring the vibrational frequency of the structure of a molecule using a laser beam. Depending on the constituent atomic masses and the molecular bond strengths, each molecule gives a unique set of vibrational frequencies ͑or sometimes termed Raman peaks͒. The distinct Raman signature of an analyte molecule renders its identification possible even from a complex background consisting of other different molecular species. For example, previous published data have shown the potential of Raman in analyzing such human samples as urine, saliva, and serum, [23] [24] [25] and even a relatively more complex sample such as cancerous lesion tissue 26 Unfortunately, Raman scattering is an inefficienct process whereby only a millionth of the incident photons is converted into Raman photons. When such a problem becomes critical, surface-enhanced Raman scattering ͑SERS͒ can be utilized. In SERS, the analyte molecule of interest is first absorbed onto metallic ͑e.g., Au or Ag͒ nanostructures and then illuminated with a laser of appropriate wavelength. If the laser wavelength matches the natural oscillating frequency of the free electrons in the nanostructures, a strong coupling will occur between the oscillating electric fields and the electrons. This results in a region of intense light energy near the edge of or in-between nanostructures ͑the so-called hot spot͒, where the absorbed molecules are strongly excited bringing about an amplified Raman scattering.
In previous SERS experiments, analyte solutions used were normally applied, in macroquantity, onto a surface bearing a properly roughened metallic structure. However, one can easily envision a commercializable SERS-based analytical device to be a hybrid of the microfluidic platform and SERSactive nanostructures. This can not only reduce the amount of materials needed in one experiment, as was discussed earlier, but at the same time offer the benefits of SERS, such as low detection limit, good chemical sensitivity and photostability ͑i.e., nonphotobleaching͒, and label-free detection, which will significantly reduce the analysis time because the incubation step is not required.
The idea of SERS-based microfluidics is not new, however, and has been published previously. 15, 20, [27] [28] [29] In most cases, metallic colloid was used as the enhancing substrates, which were introduced into the microfluidic device via one of the input ports and then directed to a mixing chamber where it interacts with the analyte of interest that was injected into the system from another port. The colloid-analyte mixture was subsequently directed into a microchannel and traverses through a focused laser beam. As the colloid-analyte flowed through the laser probe volume, SERS signals were collected. However, such a colloid-based system, unfortunately, has a disadvantage because the SERS intensities are generally dependent on the degree of aggregation of the colloid used, 27, 30, 31 which is influenced by the ionic strength of the sample and can adversely affect signal reproducibility whenever there is a large variation in the salt content between samples.
In contrast to a colloid-based system, SERS microfluidics with immobilized metallic nanostructures incorporated directly into the microchannel does not suffer from issues associated with particle agglomeration and should, in principle, exhibit better signal reproducibility. In a previous report, Liu and Lee demonstrated the use of soft lithography to fabricate immobilized nanowell SERS arrays in a SERS microfluidic biochip.
14 However, no mention was made in this particular study on the stability of the nanowell arrays toward ionicstrength variations in the sample nor was the performance of the reported device compared to that of a colloid-based system. It is therefore the primary objective of the current study to perform such a study. Specifically, we have fabricated a periodic SERS-active nanoarray in the microchannel of a SERS microfluidic and subsequently compared its performance to that of a colloid-based system by using artificial samples of different ionic strengths. Finally, as a real-world test, both systems ͑immobilized and colloid based͒ were tested and compared on human urine samples. Results are reported and discussed.
Experiment

Materials
A SU-8 50 photoresist, developer, and SU-8 thinner were purchased from MicroChem Inc. and used as received. Crystal Violet ͑CV͒ was purchased from Sigma Aldrich. Polystyrene nanosphere ͑PNS͒ was obtained from Corpuscular Inc. Sodium dodecyl sulphate ͑SDS͒, sodium citrate dihydrate, and hydrogen tetrachloroaurate ͑III͒ hydrate ͑HAuCl 4 ͒ were purchased from Sigma Aldrich Inc.
Experiment Setup
The schematic for the experiment setup is shown in Fig. 1 . Briefly, a 17-mW He-Ne 632.8 nm laser ͑Thorlab͒ was at-tenuated to ϳ5 mW using a neutral density filter ͑Edmund Inc.͒. A set of lenses, which acts as both a beam expander and spatial filter, was used to produce a 7-mm ͑Ø͒ beam of uniform profile. The so-obtained beam was then focused onto the microchannel in the microfluidics via a dichroic mirror and through an Olympus 40ϫ, 0.90 NA microscope objective. The laser power at the sample was measured to be 3.5 mW. Raman signals generated from the microfluidics were collected by the same objective and focused into a 400-m optical fiber ͑Ocean Optics, Inc.͒, which delivered the signals to a single-stage monochromator ͑DoongWo, Inc.͒. Grating used in this study was 600 g / mm, and the CCD detector ͑ANDOR Inc.͒ operating temperature was set at −60°C. A syringe pump ͑BARUN Inc.͒ was used to allow for delivering the fluidic sample into the microfluidics at a constant flow rate of 0.1 ml/ min. Waste materials from the microfluidics were collected in a beaker. An ANDOR software was used to acquire the Raman spectra as well as to control the spectrometer. Microsoft Excel was used to process the acquired spectra.
Fabrication of SU-8 Microfluidics
The procedure employed in the current study for fabricating SU-8 microfluidics was similar to those published previously but with slight modifications. 32, 33 Briefly, the SU-8 50 photoresist was first mixed well with the SU-8 thinner ͑Micro-Chem͒ at a ratio of 45:1. The mixture was then centrifuged at 500 rpm for 1 min to remove air bubbles. The addition of SU-8 thinner is necessary in order to reduce the viscosity and to aid in uniform spreading of the SU-8 50 photoresist during spinning. To produce a thin SU-8 layer, the prepared mixture was pipetted onto a cleaned 22ϫ 22 mm coverslip and made to spread out over the glass surface with a pipette tip. The sample was then subjected to spinning at 2000 rpm for 20 s to produce a SU-8 layer of uniform thickness. Prior to the UV-exposure, the sample was baked for 5 min at 65°C. Microchannel pattern to be fabricated on the SU-8 layer was printed in black using a laser printer ͑HP Colourjet͒ on a 22 ϫ 30 mm transparency, and transferred to the photoresist layer by placing the transparency between a UV-light source and the baked SU-8 layer. Upon UV exposure for 10 s, regions outside the shadow of the printed pattern polymerized, while areas defined by the image of the pattern did not and could be dissolved out with the SU-8 developer ͑Micro-Chem͒. The resultant microfluidics is shown in Fig. 2͑a͒ . Mi- 
Deposition of Polystyrene Nanospheres
A periodic monolayer of carboxylated polystryene nanospheres of ϳ397 nm in diameter was deposited in the microchannel via the technique of spin-coating. The choice of the particle size was such that the dimension of the final nanostructures would be suitable for SERS at 633 nm, which was the wavelength of the laser currently used in the experiment. Prior to spin-coating, the stock PNS solution was diluted to 2.5%, after which 0.16% of sodium dodecyl sulfate was added to minimize surface tension. SDS was used to assist uniform spreading of the nanospheres in the channel during spinning.
About 10 l of the PNS solution was applied onto the microchannel each time. Different spin conditions have been tried, and the resultant distributions of the particles in the channel were examined under a field-emission scanning electron microscope ͑FE-SEM͒. It was found that the formation of PNS monolayers was significantly impeded by the 3-D structure of the microchannel, with no close-packed monolayer formed in most cases. Anyhow, an optimal spin condition under which a monolayer of hexagonally packed particles formed was eventually obtained: Spin speed= 2000 rpm, spin time= 20 s.
Development of Metal Nanostructures
The monolayer of polystyrene spheres was overcoated with 100-nm Au layer by sputtering under a pressure of 10 −6 Torr. The finished product is checked under FE-SEM ͓see Fig. 2͑c͔͒ and then stored in a dry environment until needed.
Encapsulation of SU-8 Microfluidics
Prior to a SERS experiment, the SU-8 microfluidics bearing the SERS-active metal nanostructures was encapsulated, as depicted in Fig. 3͑a͒ , using a piece of parafilm as the sealer. Two holes matching, in position, the input and output port of the microfluidic pattern were made in the top plastic slab to allow access of liquid into the channel. The encapsulated SERS microfluidics was then placed under the microscope objective as shown in Fig. 3͑b͒ for SERS measurements. Silicon tubing of ϳ2 mm diam was used to deliver the sample into and out of the microfluidics.
Preparation of Au Colloid
A 15-nm Au colloid was synthesized by following procedures described by Grabar et al.. 34 Briefly, 25 mg of hydrogen tetrachloroaurate ͑III͒ hydrate powder was added to 200 ml of distilled water and the mixture was brought to rolling boil on a hot plate with vigorous stirring. After which, ϳ34.2 mg of sodium citrate dihydrate powder dissolved in 3 ml of distilled water was rapidly added to the vortex of the stirring tetrachloroaurate solution. Boiling continued for 10 min, during which the solution exhibited several color changes starting with yellowish then purplish and, finally, ruby-red. The final solution was stored in 4°C until needed.
Results and Discussion
Stability Test
As mentioned above, metal ͑Au or Ag͒ colloids were normally used as the Raman-enhancing substrates in the majority of previous SERS microfluidics. 15, 20 The colloid can be prepared outside the system or alternatively by pumping metal salt into the system and reducing it in situ. 15, 35 Analyte would then be introduced via a different input port and allowed to mix with the colloid inside the system. For a maximum Raman enhancement, aggregating agents were often added to induce agglomeration. 36 This unfortunately could bring about such issue as difficulties in maintaining a good control over the aggregation process. As will be shown later, indeed there exists an optimal aggregate size at which a maximum Raman enhancement can be obtained. This is mainly due to the fact that the plasmon peak of an aggregate correlates strongly with its overall size, and only those that can resonate at the excitation laser energy would give rise to strong Raman signals. 22 Thus, it is crucial that the state of aggregation of the colloid at the point of signal accumulation be reproducibly controllable. 20 This can be achieved by acquiring the Raman signals in a continuous-flow condition with a flow rate precisely adjusted in such a way the agglomerating colloid forms an optimal cluster as it passes through the laser-probe volume. 20 Though it has been demonstrated that such an approach increases the analytical precision and improves quantitation, the volume of the required materials substantiates if a long signal accumulation time is needed ͓e.g., to improve the signal to noise ratio ͑S/N͔͒. Additionally, any variation in the salt content of the samples would affect the aggregation process, and the flow rate must be readjusted to maintain a maximum enhancement. This would surely complicate the analysis as the ionic strength of each sample would have to be known a priori-an inconvenient practice especially in a large-scale clinical study.
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!"!# /#)0#1')2 *3+. To demonstrate the adverse effect the ionic strength of a sample has on a colloidal-based SERS, a model sample consisting of 1 M CV dissolved in Au colloid was used and injected into a microfludic system bearing no SERS nanostructures. The reason for choosing CV as the test analyte is its well-established SERS characteristic. 22 About 1 ml of the solution was used each time and pumped into the system at a constant flow rate of 0.1 ml/ min using the BARUN syringe pump. To simulate the effect of ionic strength, sodium chloride ͑NaCl͒ was added to the sample. There were five measurements in total, each time with a solution containing a different amount of NaCl. The NaCl concentrations used in the current study were 0, 6.5, 10.3, 34, and 65 mM. Every sample was prepared immediately before use and introduced into the microchannel within ϳ1.5 min. A new microfluidic device was used each time to avoid cross-contamination.
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!"!# /#)0#1')2 *3+. Three spectra were taken under continuous flow with a 40-s integration time for each experiment condition. Typical CV SERS spectra are shown in Fig. 4͑a͒ showing the effect of the NaCl concentrations on the SERS intensities. All spectra were agreeable with those published previously for CV. 35 A curve of the average peak intensity at 1200 cm −1 against NaCl concentrations is plotted in Fig. 4͑b͒ . It can be clearly seen that signal strengths vary by as much as six times over the concentration range considered here. Furthermore, there also exists an optimal concentration ͑10.3 mM͒ for which a maximum enhancement occurs. This corresponds to a specific aggregate size ͑see insets for transmission electron microscopy ͑TEM͒ images of the aggregates͒ that exhibits a plasmon peak matching the laser wavelength, thereby giving a maxi- !" Fig. 6 ͑a͒ Temporal changes in the urine SERS spectra obtained using a colloid-based microfluidics system. Integration time= 40 s for each spectrum. ͑b͒ Urine SERS spectrum ͑upper curve͒ obtained using microfluidics bearing periodic nanostructures, and unenhanced Raman ͑lower curve͒ of the urine sample. Integration time for the urine SERS spectrum is 40 s, and for the unenhanced Raman 200 s. Note the intensity of the unenhanced Raman spectrum has been reduced by five times from the original data in order to reduce the large background arising from the long integration time used to obtain the spectrum.
mum Raman-enhancing electromagnetic field between aggregated particles.
Next, the stability of the in-channel SERS nanostructures toward variations in the sample's ionic strength was examined. The experiment procedure described above was again used, except that no colloid was mixed in the 1 µM CV solution. Typical SERS spectra obtained with this setup is shown in Fig. 5͑a͒ and the plot of the average 1200-cm −1 peak intensity in Fig. 5͑b͒ . As expected, the immobilized nanostructures provide a much better reproducibility with a signal variation of ϳ20% over the entire concentration range compared to 137% in the colloid-based system. Furthermore, the SERS signal derived from the nanostructure bearing microfluidics remains virtually unchanged over a very long period of time ͑10 min͒. By virtue of triplicate measurements, it was estimated that signals obtained from the nanostructures can be reproduced to within 11% at a given NaCl concentration, in agreement with those previously published for a periodic SERS-active substrate. 37, 38 Last, mention should be made about the huge errors ͑ϳ30% ͒ seen in a stop-flow microfluidic system as reported previously, 20 which is a result of inhomogeneous hot-spot distribution within the solution. The smaller error seen in the current system thus implies a uniform hot-spot distribution within the periodic substrate.
SERS Study of Urine
For a real-world test, one author donates his urine sample for SERS-microfluidic analysis. The choice of a urinal fluid is twofold. First, a Raman study of urine offers a convenient tool for disease diagnosis. 23, 39, 40 For example, detection of urinal creatinine using Raman can provide information about muscular dystrophy, hyperthyroidism, and poliomyelitis. 6 Second, the high salt content as well as the large fluctuations in the ionic strength of urine offers a perfect challenge for biofluid analysis using a SERS microfluidics. 41 First, a colloid-based system was used. Initially, mixing the urine sample with the Au colloid in a 1:5 ratio results in rapid aggregation and no signal can be obtained. A second trial employing a lower urine-to-Au ratio ͑1:10͒ produces a lower aggregation rate, allowing the temporal changes of the urine SERS spectrum to be monitored. Shown in Fig. 6͑a͒ are urine SERS spectra acquired at different time points over a period of 14 min. The S/N of the spectra is somewhat poor due to the dilution of the urine sample. Nonetheless, Raman peaks corresponding to urea ͑1000 cm −1 ͒, uric acid ͑442 cm −1 ͒, Creatinine ͑690, 730, and 1082 cm −1 ͒ based on previous study, 42 can be identified in the 560-and 680-s spectra. At 880 s, however, the spectrum diminishes due to the formation of very large aggregates, which have a plasmon peak longer than the laser line. The fact that the signal undergoes a continuous change-peaks at 560s followed by a decaysuggests the instability of the colloid-based system toward the high ionic strength in the urine.
Next, microfluidics bearing the periodic nanostructures was used to study the urine sample. About 2 ml of urine was loaded into the syringe and injected into the microchannel using the syringe pump at 0.1 ml/ min. The SERS spectrum derived from this particular system is shown in Fig. 6͑b͒ ͑up-per curve͒. No appreciable signal change was observed over the 14-min interval. This suggests the stability and robustness of the nanostructures in urine analysis. Note also the better S/N in comparison to that attainable with the colloid-based system. The Raman peak corresponding to urea is more profound in this case. A prominent peak at 1607 cm −1 is not known previously in urine; thus, band assignment for this particular peak is not possible at this moment. Although one may be tempted to attribute this particular band to the SU-8 polymer, such an assumption might not be true for the following reasons: ͑i͒ no such band was observed in the Raman spectrum of the SU-8 photoresist; ͑ii͒ the SERS signals were originated mainly from the Au-coated polystyrene spheres layer; and ͑iii͒ the laser focal spot was positioned on the Aucoated spheres layer near the center of the microchannel at some distance from the SU-8 channel wall. Further investigation is thus needed with regard to the source of the 1607 cm −1 band.
For comparison, an unenhanced Raman spectrum of urine is also shown in Fig. 6͑b͒ ͑lower curve͒. The urine Raman spectrum was obtained from an undiluted urine sample using an integration time of ϳ200 s. Note that in comparison to the SERS spectrum, very few peaks are present in the unenhanced spectrum, suggesting the sensitivity of our in-channel SERS nanostructures. Also under development is an in-channel Agovercoated PNS nanostructure, which should, in principle, give a better enhancement than the Au counterpart, albeit some work would need to be done to improve the shelflife of Ag-coated microfluidics.
Conclusion
The SERS performance of colloid-based microfluidics was compared to that of microfluidics bearing periodic SERSactive nanostructures. The instability of colloid-based SERS toward variations in the ionic strength was clearly demonstrated. All in all, microfluidics with immobilized nanostructures is more stable and may be more apt for the SERS study of urine.
